<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04911088</url>
  </required_header>
  <id_info>
    <org_study_id>CELESTE-01</org_study_id>
    <nct_id>NCT04911088</nct_id>
  </id_info>
  <brief_title>Electromyographic Calibration Guided by Depth of Anesthesia</brief_title>
  <acronym>CELESTE</acronym>
  <official_title>Does Calibration of Electromyography Guided by State Entropy Improve Measurement Precision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the CELESTE study is to evaluate whether calibration of EMG is needed for&#xD;
      reliable interpretation of neuromuscular function and if so, to identify the minimal&#xD;
      necessary depth of anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuromuscular monitoring is used to document neuromuscular function intra-operatively.&#xD;
      Failure to restore neuromuscular function prior to extubation results in residual&#xD;
      neuromuscular blockade which is associated with increased postoperative morbidity and&#xD;
      mortality. It is essential to document baseline neuromuscular function before administration&#xD;
      of the neuromuscular blocking agent. However, during anesthesia induction, neuromuscular&#xD;
      monitoring is rarely calibrated due to its time-consuming nature coinciding with the&#xD;
      patients' loss of consciousness.&#xD;
&#xD;
      The CELESTE trial is a randomized, prospective, observational proof-of-concept study. We plan&#xD;
      to enroll sixty adult participants scheduled for elective non-cardiac surgery requiring&#xD;
      general anesthesia with moderate neuromuscular blockade. Participants will be randomized into&#xD;
      three electromyography (EMG) calibration groups: based on state entropy (&quot;depth of&#xD;
      anesthesia&quot;), group 1 will receive &quot;analgesic calibration&quot;, group 2 &quot;sedated calibration&quot;,&#xD;
      and group 3 &quot;no calibration&quot;. Participants will be randomly allocated to receive calibration&#xD;
      at a certain depth of anesthesia. All participants will receive a standard EMG performed on&#xD;
      the contralateral arm. Standard EMG will be calibrated at state entropy of 50.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tolerance interval of TOF ratios</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Precision of TOF measurements</measure>
    <time_frame>intraoperative</time_frame>
    <description>repeatability coefficient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agreement of EMG calibration group TOF and standard TOF</measure>
    <time_frame>intraoperative</time_frame>
    <description>Agreement of both calibration group EMG and standard EMG regarding the decision whether complete neuromuscular recovery is given based on a TOF ratio of &gt;0.9 or &gt;0.95, respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time difference between calibration group TOF and standard TOF to complete recovery</measure>
    <time_frame>intraoperative</time_frame>
    <description>Time difference between calibration group EMG and the standard EMG reaching a TOF ratio &gt;0.9 or &gt;0.95, respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recall of calibration</measure>
    <time_frame>postoperative day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort with calibration</measure>
    <time_frame>postoperative day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Analgesic calibration</arm_group_label>
    <description>Participants will receive calibration of electromyography at state entropy of 90.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedated calibration</arm_group_label>
    <description>Calibration will be started at state entropy of 70.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No calibration</arm_group_label>
    <description>Participants will not receive calibration of electromyography. Measurements will start simultaneously to the standard electromyography with a default current of 50mA at state entropy of 50.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The CELESTE study will be performed in adult patients scheduled for elective non-cardiac&#xD;
        surgery requiring general anesthesia and moderate neuromuscular blockade.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  signed informed written consent&#xD;
&#xD;
          -  BMI 17.5-30 kg/m^2&#xD;
&#xD;
          -  ASA &lt;= 3&#xD;
&#xD;
          -  supine positioning during surgery with intraoperative access to both arms&#xD;
&#xD;
          -  absence of allergy to muscle relaxants and reversal agents&#xD;
&#xD;
          -  absence of neuromuscular disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ambulatory patients for whom discharge is planned within 12 hours of anaesthesia&#xD;
&#xD;
          -  patients undergoing minor surgical&#xD;
&#xD;
          -  procedures scheduled outside the operating room&#xD;
&#xD;
          -  patients who are endotracheally intubated prior to surgery&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  indication for rapid sequence induction&#xD;
&#xD;
          -  patients undergoing arm surgery&#xD;
&#xD;
          -  patients with preceding injuries impairing muscle or nerve function of the arm (e.g.,&#xD;
             finger amputation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manfred Blobner, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Ulm, Ulm, Germany.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Flora Scheffenbichler, MD</last_name>
    <phone>004973150060284</phone>
    <email>flora.scheffenbichler@uni-ulm.de</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>June 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 2, 2021</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Ulm</investigator_affiliation>
    <investigator_full_name>Manfred Blobner</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>electromyography</keyword>
  <keyword>calibration</keyword>
  <keyword>residual paralysis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

